Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Magnetic Resonance Materials in Physics, Biology and Medicine
Published in: Magnetic Resonance Materials in Physics, Biology and Medicine 1/2018

Open Access 01-02-2018 | Review Article

Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions

Authors: Donnie Cameron, Vassilios S. Vassiliou, David M. Higgins, Peter D. Gatehouse

Published in: Magnetic Resonance Materials in Physics, Biology and Medicine | Issue 1/2018

Login to get access

Abstract

Mapping of the longitudinal relaxation time (T 1) and extracellular volume (ECV) offers a means of identifying pathological changes in myocardial tissue, including diffuse changes that may be invisible to existing T 1-weighted methods. This technique has recently shown strong clinical utility for pathologies such as Anderson-Fabry disease and amyloidosis and has generated clinical interest as a possible means of detecting small changes in diffuse fibrosis; however, scatter in T 1 and ECV estimates offers challenges for detecting these changes, and bias limits comparisons between sites and vendors. There are several technical and physiological pitfalls that influence the accuracy (bias) and precision (repeatability) of T 1 and ECV mapping methods. The goal of this review is to describe the most significant of these, and detail current solutions, in order to aid scientists and clinicians to maximise the utility of T 1 mapping in their clinical or research setting. A detailed summary of technical and physiological factors, issues relating to contrast agents, and specific disease-related issues is provided, along with some considerations on the future directions of the field.
Literature
1.
Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look–Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52(1):141–146PubMedCrossRef
2.
Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64PubMedPubMedCentralCrossRef
3.
Ugander M, Oki AJ, L-y Hsu, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33:1268–1278PubMedPubMedCentralCrossRef
4.
Kellman P, Arai AE, Xue H (2013) T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson 15:56PubMedPubMedCentralCrossRef
5.
6.
Roujol S, Weingärtner S, Foppa M, Chow K, Kawaji K, Ngo LH, Kellman P, Manning WJ, Thompson RB, Nezafat R (2014) Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 272(3):683–689PubMedPubMedCentralCrossRef
7.
Weingärtner S, Meßner NM, Budjan J, Loßnitzer D, Mattler U, Papavassiliu T, Zöllner FG, Schad LR (2016) Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson 18(1):84PubMedPubMedCentralCrossRef
8.
Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89PubMedPubMedCentralCrossRef
9.
Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 mapping basic techniques and clinical applications. JACC Cardiovasc Imaging 9(1):67–81PubMedCrossRef
10.
Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A, Knechtelsdorfer K, Wiesinger M, Pfaffenberger S, Greiser A, Lang IM, Bonderman D, Mascherbauer J (2016) T1 mapping by CMR imaging from histological validation to clinical implication. JACC Cardiovasc Imaging 9(1):14–23PubMedCrossRef
11.
Schelbert EB, Messroghli DR (2016) State of the art: clinical applications of cardiac T1 mapping. Radiology 278(3):658–676PubMedCrossRef
12.
Higgins DM, Moon JC (2014) Review of T1 mapping methods: comparative effectiveness including reproducibility issues. Curr Cardiovasc Imaging Rep 7(3):1–10CrossRef
13.
Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92PubMedPubMedCentralCrossRef
14.
Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified Look–Locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26(4):1081–1086PubMedCrossRef
15.
Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD (2010) Shortened modified Look–Locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69PubMedPubMedCentralCrossRef
16.
Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB (2014) Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med 71(6):2082–2095PubMedCrossRef
17.
Slavin GS, Hood MN, Ho VB, Stainsby JA (2012) Breath-held myocardial T1 mapping using multiple single-point saturation recovery In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 1244
18.
Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA (2005) T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys 32(6):1738–1746PubMedCrossRef
19.
Weingärtner S, Akcakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R (2014) Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med 71(3):1024–1034PubMedCrossRef
20.
Kellman P, Wilson JR, Xue H, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 14:63PubMedPubMedCentralCrossRef
21.
Messroghli DR, Rudolph A, Abdel-Aty H, Wassmuth R, Kühne T, Dietz R, Schulz-Menger J (2010) An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging 10(1):16PubMedPubMedCentralCrossRef
22.
Altabella L, Borrazzo C, Carnì M, Galea N, Francone M, Fiorelli A, Di Castro E, Catalano C, Carbone I (2017) A feasible and automatic free tool for T1 and ECV mapping. Phys Med 33:47–55PubMedCrossRef
23.
Amano Y, Takayama M, Kumita S (2009) Contrast-enhanced myocardial T1-weighted scout (Look–Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy. J Magn Reson Imaging 30(4):778–784PubMedCrossRef
24.
Nacif MS, Turkbey EB, Gai N, Nazarian S, van der Geest RJ, Noureldin RA, Sibley CT, Ugander M, Liu S, Arai AE, Lima JAC, Bluemke DA (2011) Myocardial T1 mapping with MRI: comparison of Look–Locker and MOLLI sequences. J Magn Reson Imaging 34(6):1367–1373PubMedPubMedCentralCrossRef
25.
Look DC, Locker DR (1969) Pulsed NMR by tone-burst generation. J Chem Phys 50(5):2269–2270CrossRef
26.
Look DC, Locker DR (1970) Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 41(2):250–251CrossRef
27.
Kellman P, Xue H, Chow K, Spottiswoode BS, Arai AE, Thompson RB (2014) Optimized saturation recovery protocols for T1-mapping in the heart: influence of sampling strategies on precision. J Cardiovasc Magn Reson 16:55PubMedPubMedCentralCrossRef
28.
Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD (2013) Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5T using ShMOLLI. J Cardiovasc Magn Reson 15:1CrossRef
29.
Kellman P, Bandettini WP, Mancini C, Hammer-hansen S, Hansen MS, Arai AE (2015) Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques. J Cardiovasc Magn Reson 17:33PubMedPubMedCentralCrossRef
30.
Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, Puntmann VO (2013) Standardization of T1 measurements with MOLLI in differentiation between health and disease–the ConSept study. J Cardiovasc Magn Reson 15:78PubMedPubMedCentralCrossRef
31.
Weingärtner S, Meßner NM, Zöllner FG, Akçakaya M, Schad LR (2016) Black-blood native T1 mapping: blood signal suppression for reduced partial voluming in the myocardium. Magn Reson Med. doi:10.​1002/​mrm.​26378
32.
Pagano JJ, Chow K, Yang R, Thompson RB (2014) Fat-water separated myocardial T1 mapping with IDEAL-T1 saturation recovery gradient echo imaging. J Cardiovasc Magn Reson 16(Suppl 1):P65PubMedCentralCrossRef
33.
Heng EL, Kellman P, Gatzoulis MA, Moon J, Gatehouse P, Babu-Narayan SV (2016) Quantifying right ventricular diffuse fibrosis in tetralogy of Fallot-a novel customised approach for the challenges of the right ventricle. J Cardiovasc Magn Reson 18(Suppl 1):O26PubMedCentralCrossRef
34.
Mehta BB, Chen X, Bilchick KC, Salerno M, Epstein FH (2015) Accelerated and navigator-gated Look–Locker imaging for cardiac T1 estimation (ANGIE): development and application to T1 mapping of the right ventricle. Magn Reson Med 73(1):150–160PubMedCrossRef
35.
Wang X, Joseph AA, Kalentev O, Merboldt K-D, Voit D, Roeloffs VB, van Zalk M, Frahm J (2016) High-resolution myocardial T1 mapping using single-shot inversion recovery fast low-angle shot MRI with radial undersampling and iterative reconstruction. Br J Radiol 89(1068):20160255PubMedPubMedCentralCrossRef
36.
Tsai J-M, Huang T-Y, Tseng Y-S, Lin Y-R (2012) Free-breathing MOLLI: application to myocardial T1 mapping. Med Phys 39(101):7291–7302PubMedCrossRef
37.
Weingärtner S, Akcakaya M, Roujol S, Basha T, Stehning C, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R (2015) Free-breathing post-contrast three-dimensional T1 mapping: volumetric assessment of myocardial T1 values. Magn Reson Med 73(1):214–222PubMedCrossRef
38.
Weingärtner S, Roujol S, Akcakaya M, Basha TA, Nezafat R (2015) Free-breathing multislice native myocardial T1 mapping using the slice-interleaved T1 (STONE) sequence. Magn Reson Med 74(1):115–124CrossRef
39.
Chow K, Yang Y, Shaw P, Kramer CM, Salerno M (2016) Robust free-breathing SASHA T1 mapping with high-contrast image registration. J Cardiovasc Magn Reson 18:47PubMedPubMedCentralCrossRef
40.
Kellman P, Herzka DA, Hansen MS (2014) Adiabatic inversion pulses for myocardial T1 mapping. Magn Reson Med 71(4):1428–1434PubMedCrossRef
41.
Shao J, Nguyen KL, Natsuaki Y, Spottiswoode B, Hu P (2015) Instantaneous signal loss simulation (InSiL): an improved algorithm for myocardial T1 mapping using the MOLLI sequence. J Magn Reson Imaging 41(3):721–729PubMedCrossRef
42.
Rodgers CT, Piechnik SK, DelaBarre LJ, Moortele PF, Snyder CJ, Neubauer S, Robson MD, Vaughan JT (2013) Inversion recovery at 7T in the human myocardium: measurement of T1, inversion efficiency and B1+. Magn Reson Med 70(4):1038–1046PubMedCrossRef
43.
Gai ND, Stehning C, Nacif M, Bluemke DA (2013) Modified Look–Locker T1 evaluation using Bloch simulations: human and phantom validation. Magn Reson Med 69(2):329–336PubMedCrossRef
44.
Chow K, Kellman P, Spottiswoode BS, Nielles-Vallespin S, Arai AE, Salerno M, Thompson RB (2015) Saturation pulse design for quantitative myocardial T1 mapping. J Cardiovasc Magn Reson 17:84PubMedPubMedCentralCrossRef
45.
Mueller A, Kouwenhoven M, Naehle CP, Gieseke J, Strach K, Willinek WA, Schild HH, Thomas D (2012) Dual-source radiofrequency transmission with patient-adaptive local radiofrequency shimming for 3.0-T cardiac MR imaging: initial experience. Radiology 263(1):77–85PubMedCrossRef
46.
Malik SJ, Larkman DJ, Hajnal JV (2009) Optimal linear combinations of array elements for B1 mapping. Magn Reson Med 62(4):902–909PubMedCrossRef
47.
Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S (2013) T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 70(3):664–670PubMedCrossRef
48.
Kellman P, Da Herzka, Arai AE, Hansen M (2013) Influence of off-resonance in myocardial T1-mapping using SSFP based MOLLI method. J Cardiovasc Magn Reson 15:63PubMedPubMedCentralCrossRef
49.
Bieri O (2013) Ultra-fast steady state free precession and its application to in vivo 1H morphological and functional lung imaging at 1.5 tesla. Magn Reson Med 70(3):657–663PubMedCrossRef
50.
Jung BA, Hennig J, Scheffler K (2002) Single-breathhold 3D-trueFISP cine cardiac imaging. Magn Reson Med 48(5):921–925PubMedCrossRef
51.
Deimling M, Heid O (1994) Magnetization prepared true FISP imaging. In: Proceedings of the 2nd Annual Meeting of ISMRM, San Francisco, USA, 495
52.
Deshpande VS, Chung YC, Zhang Q, Shea SM, Li D (2003) Reduction of transient signal oscillations in true-FISP using a linear flip angle series magnetization preparation. Magn Reson Med 49(1):151–157PubMedCrossRef
53.
Cameron D, Higgins DM, Stehning C, Kouwenhoven M, Bouhrara M, Frenneaux MP, Dawson DK, Redpath TW (2015) Selection of magnetization catalyzation and readout methods for modified Look–Locker inversion recovery: a T1 mapping primer. Magn Reson Imaging 33(4):363–373PubMedCrossRef
54.
Chow K, Flewitt JA, Pagano JJ, Green JD, Friedrich MG, Thompson RB (2012) MOLLI T1 values have systematic T2 and inversion efficiency dependent errors. In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 395
55.
Bieri O, Scheffler K (2013) Fundamentals of balanced steady state free precession MRI. J Magn Reson Imaging 38(1):2–11PubMedCrossRef
56.
Gruetter R, Tkáč I (2000) Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med 43(2):319–323PubMedCrossRef
57.
Schär M, Kozerke S, Fischer SE, Boesiger P (2004) Cardiac SSFP imaging at 3 tesla. Magn Reson Med 51(4):799–806PubMedCrossRef
58.
Fillmer A, Kirchner T, Cameron D, Henning A (2015) Constrained image-based B0 shimming accounting for “local minimum traps” in the optimization and field inhomogeneities outside the region of interest. Magn Reson Med 73(4):1370–1380PubMedCrossRef
59.
Shao J, Rapacchi S, Nguyen KL, Hu P (2016) Myocardial T1 mapping at 3.0 tesla using an inversion recovery spoiled gradient echo readout and bloch equation simulation with slice profile correction (BLESSPC) T1 estimation algorithm. J Magn Reson Imaging 43(2):414–425PubMedCrossRef
60.
Shao J, Rashid S, Renella P, Nguyen K-L, Hu P (2016) Myocardial T1 mapping for patients with implanted cardiac devices using wideband inversion recovery spoiled gradient echo readout. Magn Reson Med 77(4):1495–1504PubMedCrossRef
61.
Preibisch C, Deichmann R (2009) Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles. Magn Reson Med 61(1):125–135PubMedCrossRef
62.
Hong KP, Collins J, Lee DC, Wilcox JE, Markl M, Carr J, Kim D (2016) Optimized AIR and investigational MOLLI cardiac T1 mapping pulse sequences produce similar intra-scan repeatability in patients at 3T. NMR Biomed 29(10):1454–1463PubMedPubMedCentralCrossRef
63.
Bieri O, Markl M, Scheffler K (2005) Analysis and compensation of eddy currents in balanced SSFP. Magn Reson Med 54(1):129–137PubMedCrossRef
64.
Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, Plein S, C-y Yu, Otton J, Kidambi A, McDiarmid A, Broadbent D, Higgins DM, Schnackenburg B, Foote L, Cummins C, Nagel E, Puntmann VO (2014) Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:69PubMedPubMedCentralCrossRef
65.
Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P (2012) Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med 67(6):1644–1655PubMedCrossRef
66.
Ferreira VM, Wijesurendra RS, Liu A, Greiser A, Casadei B, Robson MD, Neubauer S, Piechnik SK (2015) Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias. J Cardiovasc Magn Reson 17:77PubMedPubMedCentralCrossRef
67.
Zhao L, Li S, Ma X, Greiser A, Zhang T, An J, Bai R, Dong J, Fan Z (2016) Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc Magn Reson 18:13PubMedPubMedCentralCrossRef
68.
Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA (2012) T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 14:27PubMedPubMedCentralCrossRef
69.
Fitts M, Breton E, Kholmovski EG, Dosdall DJ, Vijayakumar S, Hong KP, Ranjan R, Marrouche NF, Axel L, Kim D (2013) Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. Magn Reson Med 70(5):1274–1282PubMedCrossRef
70.
71.
Huang TY, Tseng YS, Chuang TC (2014) Automatic calibration of trigger delay time for cardiac MRI. NMR Biomed 27(4):417–424PubMedCrossRef
72.
Cain PA, Ahl R, Hedstrom E, Ugander M, Allansdotter-Johnsson A, Friberg P, Arheden H (2009) Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: a cross sectional study. BMC Med Imaging 9(1):2PubMedPubMedCentralCrossRef
73.
Bieri O, Scheffler K (2006) On the origin of apparent low tissue signals in balanced SSFP. Magn Reson Med 56(5):1067–1074PubMedCrossRef
74.
Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM (2005) T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 54(3):507–512PubMedCrossRef
75.
Donahue KM, Burstein D, Manning WJ, Gray ML (1994) Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 32(1):66–76PubMedCrossRef
76.
Flacke SJ, Fischer SE, Lorenz CH (2001) Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 218(3):703–710PubMedCrossRef
77.
Arheden H, Saeed M, Higgins CB, Gao D-W, Bremerich J, Wyttenbach R, Dae MW, Wendland MF (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211(3):698–708PubMedCrossRef
78.
Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, Klein C, Berger F, Kuehne T (2011) Assessment of diffuse myocardial fibrosis in rats using small-animal Look–Locker inversion recovery T1 mappingclinical perspective. Circ Cardiovasc Imaging 4(6):636–640PubMedCrossRef
79.
Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A (2006) Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Acad Radiol 13(7):833–839PubMedCrossRef
80.
Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Da Bluemke (2012) T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson 14:26PubMedPubMedCentralCrossRef
81.
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40(11):715–724PubMedCrossRef
82.
Pintaske J, Martirosian P, Graf H, Erb G, Lodemann K-P, Claussen CD, Schick F (2006) Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 tesla. Invest Radiol 41(3):213–221PubMedCrossRef
83.
Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D (2011) Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 13:16PubMedPubMedCentralCrossRef
84.
White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM (2013) T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 6(9):955–962PubMedCrossRef
85.
Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH (2013) Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging 38(1):217–224PubMedCrossRef
86.
Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122(2):138–144PubMedCrossRef
87.
Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441PubMedCrossRef
88.
Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295(3):H1234–H1242PubMedPubMedCentralCrossRef
89.
Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M (2010) Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 3(6):727–734PubMedPubMedCentralCrossRef
90.
Goldfarb JW, Zhao W (2014) Magnetic resonance imaging dynamic contrast enhancement (DCE) characteristics of healed myocardial infarction differ from viable myocardium. Magn Reson Imaging 32(10):1191–1197PubMedCrossRef
91.
Goldfarb JW, Zhao W (2016) Effects of transcytolemmal water exchange on the assessment of myocardial extracellular volume with cardiovascular MRI. NMR Biomed 29(4):499–506PubMedCrossRef
92.
Coelho-Filho OR, Mongeon F-P, Mitchell R, Moreno H, Nadruz W, Kwong R, Jerosch-Herold M (2013) Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging 6(1):134–141PubMedCrossRef
93.
Treibel TA, Fontana M, Maestrini V, Castelletti S, Rosmini S, Simpson J, Nasis A, Bhuva AN, Bulluck H, Abdel-Gadir A (2016) Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging 9(1):54–63PubMedCrossRef
94.
95.
Bluemke DA, Kawel-Boehm N (2016) Can a MR imaging scanner accurately measure hematocrit to determine ECV fraction? JACC Cardiovasc Imaging 9(1):64–66PubMedCrossRef
96.
Croisille P, De Bourguignon C, Chazot A, Viallon M (2017) Are synthetic haematocrit values derived from blood T1 a good substitute for blood samples to achieve accurate ECV calculation? J Cardiovasc Magn Reson 20(Suppl 1):O28
97.
Rauhalammi SM, Mangion K, Barrientos PH, Carrick DJ, Clerfond G, McClure J, McComb C, Radjenovic A, Berry C (2016) Native myocardial longitudinal (T1) relaxation time: regional, age, and sex associations in the healthy adult heart. J Magn Reson Imaging 44(3):541–548PubMedPubMedCentralCrossRef
98.
Liu C-Y, Liu Y-C, Wu C, Armstrong A, Volpe GJ, Van der Geest RJ, Liu Y, Hundley WG, Gomes AS, Liu S (2013) Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 62(14):1280–1287PubMedCrossRef
99.
Bönner F, Janzarik N, Jacoby C, Spieker M, Schnackenburg B, Range F, Butzbach B, Haberkorn S, Westenfeld R, Neizel-Wittke M (2015) Myocardial T2 mapping reveals age-and sex-related differences in volunteers. J Cardiovasc Magn Reson 17:9PubMedPubMedCentralCrossRef
100.
Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU (2006) Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution—reproducibility study 1. Radiology 238(3):1004–1012PubMedCrossRef
101.
Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJM, Schmitt M (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6(3):373–383PubMedCrossRef
102.
Atalay MK, Poncelet BP, Kantor HL, Brady TJ, Weisskoff RM (2001) Cardiac susceptibility artifacts arising from the heart-lung interface. Magn Reson Med 45(2):341–345PubMedCrossRef
103.
Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER (1998) In vivo measurement of T* 2 and field inhomogeneity maps in the human heart at 1.5T. Magn Reson Med 39(6):988–998PubMedPubMedCentralCrossRef
104.
105.
Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6(4):488–497PubMedCrossRef
106.
Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54PubMedPubMedCentralCrossRef
107.
Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, Piechnik SK, Whelan CJ, Herrey AS, Gillmore JD (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36(4):244–251PubMedCrossRef
108.
O’Mahony C, Elliott P (2010) Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 52(4):326–335PubMedCrossRef
109.
Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6(3):392–398PubMedCrossRef
110.
Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I, Oudit GY (2013) T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6(5):637–645PubMedCrossRef
111.
Pica S, Sado DM, Maestrini V, Fontana M, White SK, Treibel T, Captur G, Anderson S, Piechnik SK, Robson MD (2014) Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 16:99PubMedPubMedCentralCrossRef
112.
Hinojar R, Foote L, Ucar EA, Jackson T, Jabbour A, Yu C-Y, McCrohon J, Higgins DM, Carr-White G, Mayr M (2015) Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 8(1):37–46PubMedCrossRef
113.
Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S (2012) Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:42PubMedPubMedCentralCrossRef
114.
Dawson DK, Neil CJ, Henning A, Cameron D, Jagpal B, Bruce M, Horowitz J, Frenneaux MP (2015) Tako-tsubo cardiomyopathy: a heart stressed out of energy? JACC Cardiovasc Imaging 8(8):985–987PubMedCrossRef
115.
Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD (2013) T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 6(10):1048–1058PubMedCrossRef
116.
Dall’Armellina E, Piechnik SK, Ferreira VM, Le Si Q, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP (2012) Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 14:15PubMedPubMedCentralCrossRef
117.
Cameron D, Siddiqi N, Neil CJ, Jagpal B, Bruce M, Higgins DM, He J, Singh S, Redpath TW, Frenneaux MP (2016) T1 mapping for assessment of myocardial injury and microvascular obstruction at one week post myocardial infarction. Eur J Radiol 85(1):279–285PubMedCrossRef
118.
O h-Ici D, Jeuthe S, Al-Wakeel N, Berger F, Kuehne T, Kozerke S, Messroghli DR (2014) T1 mapping in ischaemic heart disease. Eur Heart J Cardiovasc Imaging 15(6):597–602CrossRef
119.
120.
Asanuma T, Tanabe K, Ochiai K, Yoshitomi H, Nakamura K, Murakami Y, Sano K, Shimada T, Murakami R, Morioka S (1997) Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction. Circulation 96(2):448–453PubMedCrossRef
121.
Anzalone N, Scotti R, Riva R (2004) Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 25:s3–s5PubMedCrossRef
122.
Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Gonzalez-Lopez E, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Moon JC, Hausenloy DJ (2017) Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patients. J Magn Reson Imaging. doi:10.​1002/​jmri.​25638 PubMedPubMedCentral
123.
Mordi I, Radjenovic A, Stanton T, Gardner RS, McPhaden A, Carrick D, Berry C, Tzemos N (2015) Prevalence and prognostic significance of lipomatous metaplasia in patients with prior myocardial infarction. JACC Cardiovasc Imaging 8(9):1111–1112PubMedCrossRef
124.
Rakow-Penner R, Daniel B, Yu H, Sawyer-Glover A, Glover GH (2006) Relaxation times of breast tissue at 1.5 T and 3T measured using IDEAL. J Magn Reson Imaging 23(1):87–91PubMedCrossRef
125.
Aquaro GD, Todiere G, Strata E, Barison A, Bella G, Lombardi M (2014) Usefulness of india ink artifact in steady-state free precession pulse sequences for detection and quantification of intramyocardial fat. J Magn Reson Imaging 40(1):126–132PubMedCrossRef
126.
Mozes FE, Tunnicliffe EM, Pavlides M, Robson MD (2016) Influence of fat on liver T1 measurements using modified Look–Locker inversion recovery (MOLLI) methods at 3T. J Magn Reson Imaging 44(1):105–111PubMedPubMedCentralCrossRef
127.
Kellman P, Hernando D, Shah S, Zuehlsdorff S, Jerecic R, Mancini C, Liang Z-P, Arai AE (2009) Multiecho dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med 61(1):215–221PubMedPubMedCentralCrossRef
128.
Larmour S, Chow K, Kellman P, Thompson RB (2016) Characterization of T1 bias in skeletal muscle from fat in MOLLI and SASHA pulse sequences: quantitative fat-fraction imaging with T1 mapping. Magn Reson Med 77(1):237–249PubMedCrossRef
129.
Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V, Barison A, Patel V, Herrey AS, Davies C (2015) Extracellular volume quantification in isolated hypertension-changes at the detectable limits? J Cardiovasc Magn Reson 17:74PubMedPubMedCentralCrossRef
130.
Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH (2013) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35(10):657–664PubMedPubMedCentralCrossRef
131.
Bernaba BN, Chan JB, Lai CK, Fishbein MC (2010) Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc Pathol 19(5):308–311PubMedCrossRef
132.
Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, Pierre-Mongeon F, Heydari B, Francis SA, Moslehi J, Kwong RY, Jerosch-Herold M (2013) Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol 111(5):717–722PubMedCrossRef
133.
Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CCH, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M, Wong TC (2015) Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 4(12):e002613PubMedPubMedCentralCrossRef
134.
Puntmann V (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9(1):40–50PubMedCrossRef
135.
136.
Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10(1):15–26PubMedCrossRef
137.
Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short term mortality. Circulation 126(10):1206–1216PubMedPubMedCentralCrossRef
138.
Shao J, Liu D, Sung K, Nguyen K-L, Hu P (2016) Accuracy, precision, and reproducibility of myocardial T1 mapping: a comparison of four T1 estimation algorithms for modified Look–Locker inversion recovery (MOLLI). Magn Reson Med. doi:10.​1002/​mrm.​26565 PubMedCentral
139.
Xanthis CG, Bidhult S, Kantasis G, Heiberg E, Arheden H, Aletras AH (2015) Parallel simulations for QUAntifying RElaxation magnetic resonance constants (SQUAREMR): an example towards accurate MOLLI T1 measurements. J Cardiovasc Magn Reson 17:104PubMedPubMedCentralCrossRef
140.
Sussman MS, Yang IY, Fok KH, Wintersperger BJ (2016) Inversion group (IG) fitting: a new T1 mapping method for modified Look–Locker inversion recovery (MOLLI) that allows arbitrary inversion groupings and rest periods (including no rest period). Magn Reson Med 75(6):2332–2340PubMedCrossRef
141.
Blume U, Lockie T, Stehning C, Sinclair S, Uribe S, Razavi R, Schaeffter T (2009) Interleaved T1 and T2 relaxation time mapping for cardiac applications. J Magn Reson Imaging 29(2):480–487PubMedCrossRef
142.
Kvernby S, Warntjes MJB, Haraldsson H, Carlhäll C-J, Engvall J, Ebbers T (2014) Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J Cardiovasc Magn Reson 16(1):102PubMedPubMedCentralCrossRef
143.
Santini F, Kawel-Boehm N, Greiser A, Bremerich J, Bieri O (2015) Simultaneous T1 and T2 quantification of the myocardium using cardiac balanced-SSFP inversion recovery with interleaved sampling acquisition (CABIRIA). Magn Reson Med 74(2):365–371PubMedCrossRef
144.
Akçakaya M, Weingärtner S, Basha TA, Roujol S, Bellm S, Nezafat R (2016) Joint myocardial T1 and T2 mapping using a combination of saturation recovery and T2-preparation. Magn Reson Med 76(3):888–896PubMedCrossRef
145.
146.
Hamilton JI, Jiang Y, Chen Y, Ma D, Lo WC, Griswold M, Seiberlich N (2017) MR fingerprinting for rapid quantification of myocardial T1, T2, and proton spin density. Magn Reson Med 77(4):1446–1458PubMedCrossRef
147.
Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 mapping in characterizing myocardial disease. Circ Res 119(2):277–299PubMedCrossRef
148.
Captur G, Gatehouse P, Keenan KE, Heslinga FG, Bruehl R, Prothmann M, Graves MJ, Eames RJ, Torlasco C, Benedetti G (2016) A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 mapping and ECV standardization in cardiovascular magnetic resonance (T1MES) program. J Cardiovasc Magn Reson 18:58PubMedPubMedCentralCrossRef
Metadata
Title
Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions
Authors
Donnie Cameron
Vassilios S. Vassiliou
David M. Higgins
Peter D. Gatehouse
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Magnetic Resonance Materials in Physics, Biology and Medicine / Issue 1/2018
Print ISSN: 0968-5243
Electronic ISSN: 1352-8661
DOI
https://doi.org/10.1007/s10334-017-0631-2

Other articles of this Issue 1/2018

Magnetic Resonance Materials in Physics, Biology and Medicine 1/2018 Go to the issue

Research Article

Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T 1 mapping: averaging to improve precision and correlation with collagen volume fraction

Research Article

Two-dimensional XD-GRASP provides better image quality than conventional 2D cardiac cine MRI for patients who cannot suspend respiration

Research Article

Segmental biventricular analysis of myocardial function using high temporal and spatial resolution tissue phase mapping

Editorial

Introductory editorial

Research Article

3D true-phase polarity recovery with independent phase estimation using three-tier stacks based region growing (3D-TRIPS)

Research Article

Three-dimensional black-blood multi-contrast carotid imaging using compressed sensing: a repeatability study